{
    "id": "0784",
    "question": "A 42-year-old woman presents to her obstetrician for a prenatal care appointment at 10 weeks gestation. The patient recently found out she was pregnant after having unprotected intercourse with her husband for the past year. She states that she is feeling well and has experienced some nausea and vomiting. She is currently taking prenatal vitamins and folate supplements. Her temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 127/68 mmHg, pulse is 90/min, respirations are 19/min, and oxygen saturation is 98% on room air. On physical exam, you notice a gravid uterus 10 cm above the pubic symphysis. The patient's external genitalia appear within normal limits. Which of the following is the next best step in management?",
    "options": {
        "A": "Amniocentesis",
        "B": "Cell-free DNA testing",
        "C": "Chorionic villus sampling",
        "D": "Regular follow up appointments"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine the next best step in management for this patient, we need to consider her gestational age and symptoms. At 10 weeks gestation, the patient is at a stage where various prenatal tests can be performed. Given her history of unprotected intercourse for the past year, the risk of chromosomal abnormalities such as Down syndrome is increased. However, the patient's symptoms of nausea and vomiting are common in early pregnancy and do not necessarily indicate a specific condition that requires immediate testing. The patient's physical exam is unremarkable, and there is no indication of any acute complications. The presence of a 10 cm gravid uterus is within normal limits for a 10-week gestation, which further supports the absence of any acute complications. Considering the options provided: A. Amniocentesis is typically performed between 15-20 weeks of gestation to assess for chromosomal abnormalities. At 10 weeks, it is not the most appropriate next step. B. Cell-free DNA testing (non-invasive prenatal testing or NIPT) can be performed as early as 9-10 weeks of gestation to screen for chromosomal abnormalities, including Down syndrome. However, it is not as accurate as diagnostic testing and may require follow-up testing if results are inconclusive. C. Chorionic villus sampling (CVS) is typically performed between 10-12 weeks of gestation to assess for chromosomal abnormalities. However, it carries a small risk of miscarriage and is usually reserved for cases where NIPT results are inconclusive or if there are other concerns. D. Regular follow-up appointments are crucial in monitoring the pregnancy, but given the patient's increased risk of chromosomal abnormalities due to her history of unprotected intercourse, further testing is warranted. Given these considerations, the most appropriate next step is B. Cell-free DNA testing, as it can be performed at 10 weeks gestation and provides valuable information about the risk of chromosomal abnormalities, including Down syndrome. However, it is essential to note that the results should be discussed with the patient and follow-up testing may be necessary if results are inconclusive or if there are other concerns.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 52.77140235900879
}